All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Completed, but no date | 2016-000945-29 | Activity of Abiraterone Acetate in the management of Cushing’s syndrome in patients with adrenocortical carcinoma (ABACUS) Attività di Abiraterone nel trattamento della sindrome di Cushing in pazie... | bad-data | |
| Completed, but no date, and reported results | 2016-004210-10 | A PILOT PHASE IV STUDY TO EVALUATE VARIATION IN BONE MINERAL DENSITY, LEAN AND FAT BODY MASS MEASURED BY DUAL-ENERGY X-RAY ABSORPTIOMETRY IN PATIENTS WITH PROSTATE CANCER WITHOUT BONE METASTASIS TREA... | bad-data | |
| Not reported | 2017-000305-21 | Assessment of bone response after LHRH-A and Enzalutamide plus minus Zoledronic Acid in prostate cancer patients with hormone sensitive metastatic bone disease: a prospectic, phase II, randomized, mul... | 2023-04-18 | due-trials |
| Ongoing | 2017-001591-35 | Multicenter, prospective, non-randomized, phase II trial designed to evaluate the activity of Cabazitaxel in patients with advanced Adreno-Cortical- Carcinoma progressing after previous chemotherapy l... | not-yet-due | |
| Ongoing | 2018-000580-90 | Multicenter randomized open-label phase III trial of Adjuvant Chemotherapy vs. observation or mitotane after primary surgical resection of localized Multicenter randomized open-label phase III tri... | not-yet-due | |
| Ongoing | 2019-000364-24 | Randomized open label multicentric phase II trial of Adjuvant RadioChemotherapy, Concurrent versus Sequential, in resected non-small cell lung cancer (NSCLC) patients with mediastinal involvement (pN2... | not-yet-due | |
| Completed, but no date Terminated | 2019-002063-95 | A Phase 3, Open, Randomized controlled trial on Completion Rate of daily Rifapentine/Isoniazid for One Month Compared with Daily Rifampicin/Isoniazid for Three Months for the Treatment of Latent Tuber... | bad-data | |
| Ongoing | 2020-000295-38 | Phase II trial, open label, single-arm, of Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions Studio di fase II, in aperto, a braccio singolo su inibitore del checkpoint immunitario... | not-yet-due | |
| Ongoing | 2020-004530-38 | PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOTANE IN PATIENTS WITH ADVANCED ADRENALCORTICAL (PESETA TRIAL)... | not-yet-due | |
| Ongoing | 2020-005754-23 | Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA Trial) RADIOTERAPIA STEREOTASSICA PROSTATICA CON O SENZA T... | not-yet-due | |
| Ongoing | 2021-000520-35 | Multiparametric assessment of bone response in mCRPC patients treated with Cabozantinib upon progression to chemotherapy and next generation hormonal agents: a phase II study VALUTAZIONE MULTIPARAM... | not-yet-due | |
| Ongoing | 2021-001438-20 | Randomized controlled trial on daily Rifampicin for Four Months Compared with daily Rifampicin/Isoniazid for Three Months for the Treatment of Tuberculosis Infection among migrants: Completion Rate an... | not-yet-due | |
| Ongoing | 2021-006515-28 | Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell Transplantation (allo-SCT) in Acute Myeloid Leukemia (AML) p... | not-yet-due | |
| Ongoing | 2022-002841-17 | Phase 2, open-label, multicentre, single-arm study to evaluate the activity of the combination of EGFR inhibitors and c-MET inhibitors in patients with platinum-resistant head and neck squamous cell c... | not-yet-due | |
| Ongoing | 2022-003206-69 | A multicenter, randomized, open-label, controlled study to evaluate the efficacy and safety of corticoSTEROids added to standard therapy in patients with Acute Heart Failure (STERO-AHF) Studio mult... | not-yet-due | |
| Ongoing | 2022-004188-25 | P-ACC Trial - Phase II, single arm, multicenter, open-label study of PARP inhibitors + cisplatin in Recurrent and/or Metastatic Adenoid Cystic Carcinoma P-ACC Trial: Studio di fase II; singolo brac... | not-yet-due |